Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
109,406
+7,983
+8% +$213K 0.71% 41
2025
Q4
$2.53M Sell
101,423
-4,247
-4% -$107K 0.62% 48
2025
Q3
$2.69M Buy
105,670
+5,089
+5% +$126K 0.68% 44
2025
Q2
$2.44M Buy
100,581
+11,288
+13% +$263K 0.67% 46
2025
Q1
$2.26M Buy
89,293
+7,218
+9% +$189K 0.67% 52
2024
Q4
$2.18M Sell
82,075
-6,528
-7% -$177K 0.63% 55
2024
Q3
$2.56M Sell
88,603
-3,545
-4% -$103K 0.71% 44
2024
Q2
$2.58M Buy
92,148
+1,769
+2% +$48.7K 0.77% 41
2024
Q1
$2.51M Buy
90,379
+8,603
+11% +$239K 0.77% 42
2023
Q4
$2.35M Sell
81,776
-15,134
-16% -$457K 0.78% 43
2023
Q3
$3.21M Buy
+96,910
New +$3.43M 1.17% 15
2023
Q1
$4.04M Sell
96,566
-1,046
-1% -$45.2K 1.45% 6
2022
Q4
$5M Sell
97,612
-961
-1% -$46.1K 1.88% 4
2022
Q3
$4.35M Buy
98,573
+627
+0.6% +$30.5K 1.73% 6
2022
Q2
$5.06M Sell
97,946
-458
-0.5% -$23.3K 1.96% 3
2022
Q1
$5.08M Sell
98,404
-2,130
-2% -$111K 1.73% 5
2021
Q4
$5.51M Buy
100,534
+2,151
+2% +$107K 1.87% 5
2021
Q3
$4.13M Buy
98,383
+955
+1% +$42.3K 1.5% 9
2021
Q2
$3.89M Buy
97,428
+106
+0.1% +$4.12K 1.4% 10
2021
Q1
$3.53M Buy
97,322
+201
+0.2% +$7.14K 1.38% 15
2020
Q4
$3.58M Sell
97,121
-4,256
-4% -$156K 1.55% 13
2020
Q3
$3.53M Buy
101,377
+3,009
+3% +$105K 1.74% 11
2020
Q2
$3.05M Buy
98,368
+3,823
+4% +$130K 1.6% 15
2020
Q1
$2.93M Buy
94,545
+2,243
+2% +$76.4K 1.79% 10
2019
Q4
$3.4M Buy
92,302
+866
+0.9% +$30.8K 1.64% 12
2019
Q3
$3.12M Sell
91,436
-600
-0.7% -$21.8K 1.63% 10
2019
Q2
$3.88M Buy
92,036
+305
+0.3% +$12.1K 1.99% 6
2019
Q1
$3.7M Sell
91,731
-3,040
-3% -$122K 1.94% 5
2018
Q4
$3.8M Buy
+94,771
New +$3.93M 2.13% 3
2018
Q2
$3.16M Buy
+91,831
New +$3.14M 1.7% 9

Other funds holding PFE

Old Port Advisors's PFE Position: Q1 2026 in Review

Old Port Advisors increased its Pfizer (PFE) stake by 7.9% in Q1 2026, buying an estimated $213K and bringing the position to 109,406 shares worth $3.07M. The position accounts for 0.71% of the portfolio, ranked #41.

Old Port Advisors first reported a position in PFE in Q2 2018 and has held it in 30 quarters since. The position peaked at $5.51M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Old Port Advisors held 109,406 shares of Pfizer worth $3.07M as of Q1 2026.
  • Old Port Advisors bought 7,983 Pfizer shares in Q1 2026, an estimated $213K.
  • Pfizer made up 0.71% of Old Port Advisors's portfolio in Q1 2026, its #41 holding.
  • Old Port Advisors first reported a position in Pfizer in Q2 2018 and has held it in 30 quarters since.
  • Old Port Advisors's Pfizer position peaked at $5.51M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Old Port Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.